AI predicts lymph node spread in stomach cancer using scans and biopsy
Part of Cancer clinical trials.
This study uses artificial intelligence to predict whether stomach cancer has spread to nearby lymph nodes. By analyzing your CT/MRI scans and biopsy results before surgery, the AI may help doctors plan your treatment more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of gastric adenocarcinoma (a type of stomach cancer).
- You are scheduled for surgery to remove part or all of your stomach (gastrectomy) and nearby lymph nodes.
- You have had a CT or MRI scan of your belly with contrast dye before surgery.
- You have a biopsy report from a tissue sample taken from your stomach cancer.
- You have not had chemotherapy, radiation, or major belly surgery in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze your CT scan and predict whether stomach cancer has spread to lymph nodes behind your belly. The goal is to help doctors decide if you need more extensive surgery.
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
This trial is testing a new artificial intelligence (AI) model to help doctors better identify whether gastric cancer has spread to nearby lymph nodes. If you qualify, you may help improve how this cancer is diagnosed and treated, without any extra invasive procedures.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
Hear when a new Gastric Cancer Adenocarcinoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.